SPIRONOLACTONE ALTIZIDE ZENTIVA 25 mg/15 mg, scored tablet 90 tablets
Active ingredients: Altizide, Spironolactone
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPIRONOLACTONE ALTIZIDE ZENTIVA 25 mg/15 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC de 90 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Mar 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62127360CIP73787420CIP133400937874205Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SPIRONOLACTONEcomprimé | 0,025 g · un comprimé | SA |
| ALTIZIDEcomprimé | 0,015 g · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.